Table 2.
Oral glucose tolerance tests at baseline and Week 12.
| Clinical Test Item | Placebo (n = 18) | Kestose (n = 20) | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Week 12 | Baseline | Week 12 | |||||
| Glucose (mg/dL) | ||||||||
| 0 min | 85.9 | (5.5) | 86.7 | (7.5) | 87.2 | (11.4) | 88.6 | (8.3) |
| 30 min | 136.0 | (21.3) | 132.1 | (19.7) | 145.1 | (23.4) | 142.4 | (28.6) |
| 60 min | 137.7 | (35.8) | 132.4 | (46.7) | 140.5 | (46.7) | 151.3 | (45.1) |
| 90 min | 122.3 | (28.3) | 118.5 | (32.9) | 126.6 | (38.5) | 121.4 | (35.9) |
| 120 min | 109.4 | (19.4) | 105.5 | (20.6) | 115.8 | (29.3) | 100.4 | (21.3) * |
| AUC [(mg/dL)h] | 75.1 | (37.2) | 67.7 | (43.0) | 84.3 | (48.0) | 78.1 | (48.2) |
| Insulin (µU/mL) | ||||||||
| 0 min | 6.2 | (1.7) | 6.5 | (2.1) | 6.5 | (4.0) | 5.3 | (1.4) |
| 30 min | 46.5 | (35.2) | 45.9 | (23.8) | 43.9 | (33.7) | 29.2 | (13.2) |
| 60 min | 45.5 | (21.0) | 49.2 | (24.2) | 39.7 | (21.7) | 42.7 | (19.9) |
| 90 min | 40.3 | (17.6) | 38.1 | (19.9) | 35.6 | (21.3) | 35.9 | (21.0) |
| 120 min | 35.5 | (18.1) | 36.6 | (13.5) | 34.8 | (22.0) | 36.5 | (27.9) |
| AUC [(µU/mL)min] | 128.3 | (58.9) | 128.7 | (53.3) | 113.9 | (55.7) | 107.5 | (52.0) |
Data are presented as mean (SD). Abbreviation: AUC, area under the curve. * p < 0.05 vs. Baseline value of the kestose group.